<VariationArchive VariationID="12585" VariationName="NM_033360.4(KRAS):c.27_29dup (p.Gly10dup)" VariationType="Duplication" Accession="VCV000012585" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2016-09-08" MostRecentSubmission="2016-09-08">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="27624" VariationID="12585">
      <GeneList>
        <Gene Symbol="KRAS" FullName="KRAS proto-oncogene, GTPase" GeneID="3845" HGNC_ID="HGNC:6407" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12p12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="25205246" stop="25250929" display_start="25205246" display_stop="25250929" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="25358179" stop="25403853" display_start="25358179" display_stop="25403853" Strand="-" />
          </Location>
          <OMIM>190070</OMIM>
          <Haploinsufficiency last_evaluated="2015-10-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KRAS">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-10-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KRAS">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_033360.4(KRAS):c.27_29dup (p.Gly10dup)</Name>
      <CanonicalSPDI>NC_000012.12:25245355:CCA:CCACCA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12p12.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="25245355" stop="25245356" display_start="25245355" display_stop="25245356" variantLength="3" positionVCF="25245355" referenceAlleleVCF="T" alternateAlleleVCF="TCCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="25398289" stop="25398290" display_start="25398289" display_stop="25398290" variantLength="3" positionVCF="25398289" referenceAlleleVCF="T" alternateAlleleVCF="TCCA" />
      </Location>
      <OtherNameList>
        <Name>KRAS, 3-BP INS, GLY11INS</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_344t2" sequenceAccession="LRG_344t2" change="c.27_29dup">
            <Expression>LRG_344t2:c.27_29dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_344p2" sequenceAccession="LRG_344p2" change="p.Gly10dup">
            <Expression>LRG_344p2:p.Gly10dup</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_344t1" sequenceAccession="LRG_344t1" change="c.27_29dup">
            <Expression>LRG_344t1:c.27_29dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_344p1" sequenceAccession="LRG_344p1" change="p.Gly10dup">
            <Expression>LRG_344p1:p.Gly10dup</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_344" sequenceAccession="LRG_344" change="g.10646_10648dup">
            <Expression>LRG_344:g.10646_10648dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.25398290_25398292dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.25398290_25398292dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.25245356_25245358dup" Assembly="GRCh38">
            <Expression>NC_000012.12:g.25245356_25245358dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007524.2" sequenceAccession="NG_007524" sequenceVersion="2" change="g.10646_10648dup">
            <Expression>NG_007524.2:g.10646_10648dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369786.1" sequenceAccession="NM_001369786" sequenceVersion="1" change="c.27_29dup">
            <Expression>NM_001369786.1:c.27_29dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356715.1" sequenceAccession="NP_001356715" sequenceVersion="1" change="p.Gly10dup">
            <Expression>NP_001356715.1:p.Gly10dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369787.1" sequenceAccession="NM_001369787" sequenceVersion="1" change="c.27_29dup">
            <Expression>NM_001369787.1:c.27_29dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356716.1" sequenceAccession="NP_001356716" sequenceVersion="1" change="p.Gly10dup">
            <Expression>NP_001356716.1:p.Gly10dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004985.5" sequenceAccession="NM_004985" sequenceVersion="5" change="c.27_29dup" MANESelect="true">
            <Expression>NM_004985.5:c.27_29dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004976.2" sequenceAccession="NP_004976" sequenceVersion="2" change="p.Gly10dup">
            <Expression>NP_004976.2:p.Gly10dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033360.4" sequenceAccession="NM_033360" sequenceVersion="4" change="c.27_29dup" MANEPlusClinical="true">
            <Expression>NM_033360.4:c.27_29dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_203524.1" sequenceAccession="NP_203524" sequenceVersion="1" change="p.Gly10dup">
            <Expression>NP_203524.1:p.Gly10dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA280165" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="190070.0008" DB="OMIM" />
        <XRef Type="rs" ID="606231202" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 8955068 Fig. 1 to determine the location of this allele on the current reference sequence. </Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_033360.4(KRAS):c.27_29dup (p.Gly10dup) AND Acute myeloid leukemia" Accession="RCV000013415" Version="32">
        <ClassifiedConditionList TraitSetID="6288">
          <ClassifiedCondition DB="MedGen" ID="C0023467">Acute myeloid leukemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1996-12-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1996-12-20" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-09-08" MostRecentSubmission="2016-09-08">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">8955068</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6288" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15736" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Leukemia, acute myeloid, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukemia, acute myelogenous, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute myeloid leukemia, adult</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AML adult</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute myelogenous leukemia</ElementValue>
                <XRef ID="Acute+Myeloid+Leukemia%2C+Adult/204" DB="Genetic Alliance" />
                <XRef ID="HP:0004808" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute non-lymphocytic leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute granulocytic leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Acute myeloid leukemia</ElementValue>
                <XRef ID="HP:0004808" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0018874" DB="MONDO" />
                <XRef ID="519" DB="Orphanet" />
                <XRef ID="17788007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AML</ElementValue>
                <XRef ID="GTR000500636" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="601626" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise specified. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification)</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism">Constitutively activated FLT3</Attribute>
                <XRef ID="GTR000552464" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12757" />
                <XRef ID="12757" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20963938</ID>
                <ID Source="BookShelf">NBK47457</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011">
                <ID Source="PubMed">22138009</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2013">
                <ID Source="PubMed">23970018</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33226740</ID>
                <ID Source="BookShelf">NBK564234</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33661592</ID>
                <ID Source="BookShelf">NBK568319</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34723452</ID>
                <ID Source="BookShelf">NBK574843</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2020">
                <ID Source="PubMed">32171751</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/all.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Acute Lymphoblastic Leukemia, 2024</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Acute Myeloid Leukemia, 2023</CitationText>
              </Citation>
              <XRef ID="519" DB="Orphanet" />
              <XRef ID="C0023467" DB="MedGen" />
              <XRef ID="D015470" DB="MeSH" />
              <XRef ID="MONDO:0018874" DB="MONDO" />
              <XRef Type="MIM" ID="601626" DB="OMIM" />
              <XRef Type="primary" ID="HP:0004808" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001914" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004843" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005516" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006724" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006728" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="33662" SubmissionDate="2016-09-02" DateLastUpdated="2016-09-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="190070.0008_LEUKEMIA, ACUTE MYELOGENOUS, SOMATIC" title="KRAS, 3-BP INS, GLY11INS_LEUKEMIA, ACUTE MYELOGENOUS, SOMATIC" />
        <ClinVarAccession Accession="SCV000033662" DateUpdated="2016-09-08" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1996-12-20">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In the bone marrow of a 4-year-old child with acute myeloid leukemia (AML; 601626), Bollag et al. (1996) identified an in-frame 3-bp insertion in exon 1 of the KRAS2 gene, resulting in an insertion of gly11. Expression of the mutant protein in NIH 3T3 cells caused cellular transformation, and expression in COS cells activated the RAS-mitogen-activated protein kinase signaling pathway. RAS-GTP levels measured in COS cells established that this novel mutant accumulates up to 90% in the GTP state, considerably higher than a residue 12 mutant. This mutation was the first dominant RAS mutation found in human cancer that did not involve residues 12, 13, or 61.</Attribute>
              <Citation>
                <ID Source="PubMed">8955068</ID>
              </Citation>
              <XRef DB="OMIM" ID="601626" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KRAS" />
          </GeneList>
          <Name>KRAS, 3-BP INS, GLY11INS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP INS, GLY11INS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="190070.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LEUKEMIA, ACUTE MYELOGENOUS, SOMATIC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="33662" TraitType="Disease" MappingType="Name" MappingValue="LEUKEMIA, ACUTE MYELOGENOUS, SOMATIC" MappingRef="Preferred">
        <MedGen CUI="C0023467" Name="Acute myeloid leukemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

